Implantation of drug-eluting stents (DESs) via percutaneous coronary intervention is the
most popular treatment option to restore blood flow to occluded vasculature. The many …

The clinical importance of drug-eluting stents (DESs) has been demonstrated by their
unparalleled success in preventing restenosis after stenting procedures. The magnitude of …

Current drug eluting stent (DES) technology is not optimized with regard to the
pharmacokinetics of drug delivery. A novel, absorbable-coating sirolimus-eluting stent (AC …

This review focuses on describing new generations of drug-eluting stents (DES) based on
the use of novel stent platforms, coatings, and carrier systems, developed to enhance DES …

Drug-eluting stents (DES) have become more widely used by cardiologists than bare metal
stents (BMS) because of their better ability to control restenosis. However, recognized …

Coronary stenting is the most common form of interventional treatment for symptomatic
coronary artery disease. In-stent restenosis following bare metal stent (BMS) placement is …

protein binding, and molecular weight and charge. For example, the release of protein-
binding drugs should be examined in protein-containing solutions. Elution features may …

The objective of this work was to prepare a biocompatible and degradable polymer coating
for vascular stents that would release a restenosis inhibitor for a sustained period of time. To …

Drug‐eluting stents (DES) revolutionized cardiovascular treatment by virtually eliminating in‐
stent restanosis. However, in the past 3 years the US Food and Drug Administration and …

Drug-eluting stents (DES) were primarily conceived to re-duce in-stent neointimal formation
and therefore minimize the occurrence of restenosis, the major drawback of percutaneous …